T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Target
TGT
$69.9B
| $83.4M | 0.01% |
962,742
+13,877
| +1% | +$1.12M |
|
702
CALL
Conagra Brands
CAG
$7.16B
| $83.1M | 0.01% |
3,131,800
| – | – |
|
703
Primerica
PRI
$9.57B
| $82.8M | 0.01% |
690,674
-5,692
| -0.8% | -$705K |
|
704
East-West Bancorp
EWBC
$18.5B
| $82.6M | 0.01% |
1,765,284
+686,664
| +64% | +$32.9M |
|
705
KT
KT
$8.83B
| $82.2M | 0.01% |
6,644,815
-266,700
| -4% | -$3.25M |
|
706
Colliers International
CIGI
$5.15B
| $82M | 0.01% |
1,145,500
-1,100
| -0.1% | -$72.6K |
|
707
Aflac
AFL
$60.5B
| $81.5M | 0.01% |
1,487,729
-37,601
| -2% | -$1.94M |
|
|
CIR
708
DELISTED
CIRCOR International, Inc
CIR
| $81.3M | 0.01% |
1,767,816
-15,544
| -0.9% | -$602K |
|
709
Knowles
KN
$3.33B
| $81.3M | 0.01% |
4,439,568
-26,947
| -0.6% | -$475K |
|
710
Ingevity
NGVT
$2.62B
| $81M | 0.01% |
769,845
-3,382
| -0.4% | -$340K |
|
711
Truist Financial
TFC
$64.3B
| $80.7M | 0.01% |
1,642,426
+7,749
| +0.5% | +$380K |
|
712
Insperity
NSP
$1.92B
| $80.1M | 0.01% |
655,601
+2,492
| +0.4% | +$300K |
|
713
TransDigm Group
TDG
$68.3B
| $79.8M | 0.01% |
164,902
+3,728
| +2% | +$1.74M |
|
714
Constellium
CSTM
$4B
| $79.1M | 0.01% |
7,882,295
-77,763
| -1% | -$720K |
|
715
Glacier Bancorp
GBCI
$6.4B
| $78.7M | 0.01% |
1,939,872
-96,427
| -5% | -$3.96M |
|
716
Charles River Laboratories
CRL
$13.6B
| $78.6M | 0.01% |
554,103
-1,382
| -0.2% | -$187K |
|
717
Tyler Technologies
TYL
$13B
| $78.1M | 0.01% |
361,473
+105
| +0% | +$22.8K |
|
718
Welltower
WELL
$166B
| $77.9M | 0.01% |
955,407
+263,246
| +38% | +$20.7M |
|
719
Mueller Water Products
MWA
$4.09B
| $77.6M | 0.01% |
7,906,692
-1,196,754
| -13% | -$12M |
|
|
MLNX
720
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $77.2M | 0.01% |
697,870
-4,759
| -0.7% | -$548K |
|
721
American Public Education
APEI
$826M
| $77.2M | 0.01% |
2,609,613
-367,904
| -12% | -$11.3M |
|
|
SUM
722
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $77M | 0.01% |
4,068,668
-119,683
| -3% | -$1.9M |
|
|
GWPH
723
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $76.8M | 0.01% |
445,558
-27,550
| -6% | -$4.77M |
|
724
Globant
GLOB
$1.67B
| $76.7M | 0.01% |
759,367
-639,890
| -46% | -$55.8M |
|
725
McGrath RentCorp
MGRC
$2.94B
| $76.7M | 0.01% |
1,233,304
-27,911
| -2% | -$1.67M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.